CLINICAL_TRIALS
trial_result
· 2024-11-22
Clinical Trial Update: Clinical Study of NPC-12Y Gel in Patients With Skin Lesions Associated With TSC [Phase 3]
Summary
Phase 3 clinical trial evaluating NPC-12Y Gel for skin lesions in Tuberous Sclerosis Complex has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nobelpharma | Conditions: Tuberous Sclerosis Complex | Phase 3 | Status: COMPLETED